West-ward 3189 (Lithium 300 mg)
Pill imprint West-ward 3189 has been identified as Lithium carbonate 300 mg.
Lithium is used in the treatment of bipolar disorder; borderline personality disorder; schizoaffective disorder; mania; cluster headaches (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for West-ward 3189
- 300 mg
- Gray & Yellow
- 20.00 mm
- Prescription only
- Drug Class:
- Miscellaneous antipsychotic agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- West-Ward Pharmaceutical Corporation
- National Drug Code (NDC):
- Inactive Ingredients:
- magnesium silicate
FD&C Green No. 3
FD&C Yellow No. 6
|NDC Code||Manufacturer / Repackager|
|63739-0265||McKesson Packaging Services|
|16590-0781||Stat RX USA LLC (repackager)|
|43063-0196||PDRX Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about lithium
- Lithium controlled-release and extended-release tablets
- Lithium syrup
- Lithium (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.